Published 11/02/2009 by FierceBiotech
Probiodrug gains $54M to back Alzheimer's program
The early-stage German biotech Probiodrug AG won an impressive $54 million in fresh venture capital backing in one of the largest biotech rounds reported this year. The second round was led by BB Biotech and Edmond de Rothschild Investment Partners with LSP Life Science Partners and Biogen Idec New...
Share this
What others report on the same story